Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,352 | -30,970 | -96,655 | -69,883 | -48,381 |
| Depreciation Amortization | 182 | 88 | 377 | 289 | 199 |
| Accounts payable and accrued liabilities | 1,656 | 4,958 | 2,324 | 1,833 | 1,251 |
| Other Working Capital | 3,457 | 4,544 | -589 | -6,393 | -1,814 |
| Other Operating Activity | 5,006 | -2,116 | 10,816 | 8,903 | 6,238 |
| Operating Cash Flow | $-51,051 | $-23,496 | $-83,727 | $-65,251 | $-42,507 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -159 | -153 | 14 | 14 | N/A |
| Purchase Of Investment | -158,254 | -76,091 | -255,625 | -170,710 | -74,760 |
| Sale Of Investment | 133,391 | 56,100 | 250,760 | 196,760 | 126,260 |
| Investing Cash Flow | $-25,022 | $-20,144 | $-4,851 | $26,064 | $51,500 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 24,426 | 8,821 | 133,415 | 132,892 | 2,263 |
| Financing Cash Flow | $24,426 | $8,821 | $133,415 | $132,892 | $2,263 |
| Beginning Cash Position | 68,539 | 68,539 | 23,702 | 23,702 | 23,702 |
| End Cash Position | 16,892 | 33,720 | 68,539 | 117,407 | 34,958 |
| Net Cash Flow | $-51,647 | $-34,819 | $44,837 | $93,705 | $11,256 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,051 | -23,496 | -83,727 | -65,251 | -42,507 |
| Capital Expenditure | -159 | -153 | N/A | N/A | N/A |
| Free Cash Flow | -51,210 | -23,649 | -83,727 | -65,251 | -42,507 |